The effects of cannabidiol (CBD) on Δ9-tetrahydrocannabinol (thc) self-administration in male and female Long-Evans rats

Experimental and Clinical Psychopharmacology

Volumn 25, Issue 4, 2017, Pages 242-248

  Wakeford, Alison G P ^a   Wetzell, Bradley B ^a   Pomfrey, Rebecca L ^a   Clasen, Matthew M ^a   Taylor, William W ^a   Hempel, Briana J ^a   Riley, Anthony L ^a  

^a American University   (United States)

Author keywords

CBD; Drug interaction; Self administration; Sex differences; THC

Indexed keywords

CANNABIDIOL; COCAINE; DRONABINOL;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AVERSION; CANNABIS ADDICTION; CANNABIS USE; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG EFFECT; DRUG SELF ADMINISTRATION; DRUG SENSITIVITY; FEMALE; LONG EVANS RAT; MALE; NONHUMAN; RAT; REINFORCEMENT; SEX DIFFERENCE; ANIMAL; DOSE RESPONSE; INTRAVENOUS DRUG ADMINISTRATION;

ADMINISTRATION, INTRAVENOUS; ANIMALS; CANNABIDIOL; COCAINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRONABINOL; FEMALE; MALE; RATS; RATS, LONG-EVANS; SELF ADMINISTRATION; SEX FACTORS;

EID: 85021806354     PISSN: 10641297     EISSN: 19362293     Source Type: Journal    
DOI: 10.1037/pha0000135     Document Type: Article

References (64)

1. Amchova, P., Kucerova, J., Giugliano, V., Babinska, Z., Zanda, M. T., Scherma, M.,. Fattore, L. (2014). Enhanced self-administration of the CB1 receptor agonist WIN55,212-2 in olfactory bulbectomized rats: Evaluation of possible serotonergic and dopaminergic underlying mech- anisms. Frontiers in Pharmacology, 5, 44. https://doi.org/10.3389/fphar .2014.00044
2. Becker, J. B., & Koob, G. F. (2016). Sex differences in animal models: Focus on addiction. Pharmacological Reviews, 68, 242-263. http://dx .doi.org/10.1124/pr.115.011163
3. Bhattacharyya, S., Morrison, P. D., Fusar-Poli, P., Martin-Santos, R., Borgwardt, S., Winton-Brown, T.,. McGuire, P. K. (2010). Opposite effects of delta-9-tetrahydrocannabinol and cannabidiol on human brain function and psychopathology. Neuropsychopharmacology, 35, 764-774. http://doi.org/10.1038/npp.2009.184
4. Brady, J. V., Griffiths, R. R., Hienz, R. D., Ator, N. A., Lukas, S. E., & Lamb, R. J. (1987). Assessing drugs for abuse liability and dependence potential in laboratory primates. New York, NY: Springer. http://dx.doi .org/10.1007/978-1-4612-4812-5_3
5. Caine, S. B., & Koob, G. F. (1994). Effects of dopamine D-1 and D-2 antagonists on cocaine self-administration under different schedules of reinforcement in the rat. The Journal of Pharmacology and Experimental Therapeutics, 270, 209-218.
6. Carroll, M. E., Morgan, A. D., Lynch, W. J., Campbell, U. C., & Dess, N. K. (2002). Intravenous cocaine and heroin self-administration in rats selectively bred for differential saccharin intake: Phenotype and sex differences. Psychopharmacology, 161, 304-313. http://dx.doi.org/10 .1007/s00213-002-1030-5
7. Center for Behavioral Health Statistics and Quality. (2015). Behavioral health trends in the United States: Results from the 2014 National Survey on Drug Use and Health (HHS Publication No. SMA 15-4927, NSDUH Series H-50). Retrieved from https://www.samhsa.gov/data/ sites/default/files/NSDUH-FRR1-2014/NSDUH-FRR1-2014.pdf
8. Chaudhri, N., Caggiula, A. R., Donny, E. C., Booth, S., Gharib, M. A., Craven, L. A.,. Perkins, K. A. (2005). Sex differences in the contribution of nicotine and nonpharmacological stimuli to nicotine self-administration in rats. Psychopharmacology, 180, 258-266. http:// doi.org/10.1007/s00213-005-2152-3
9. Cheng, H. Y. M., Laviolette, S. R., van der Kooy, D., & Penninger, J. M. (2004). DREAM ablation selectively alters THC place aversion and analgesia but leaves intact the motivational and analgesic effects of morphine. The European Journal of Neuroscience, 19, 3033-3041. http://dx.doi.org/10.1111/j.0953-816X.2004.03435.x
10. Collins, R. J., Weeks, J. R., Cooper, M. M., Good, P. I., & Russell, R. R. (1984). Prediction of abuse liability of drugs using IV selfadministration by rats. Psychopharmacology, 82, 6-13. http://dx.doi .org/10.1007/BF00426372
11. Copeland, J., & Swift, W. (2009). Cannabis use disorder: Epidemiology and management. International Review of Psychiatry, 21, 96-103. http://dx.doi.org/10.1080/09540260902782745
12. Corcoran, M. E., & Amit, Z. (1974). Reluctance of rats to drink hashish suspensions: Free-choice and forced consumption, and the effects of hypothalamic stimulation. Psychopharmacology, 35, 129-147. http://dx .doi.org/10.1007/BF00429580
13. Degenhardt, L., Ferrari, A. J., Calabria, B., Hall, W. D., Norman, R. E., McGrath, J.,. Vos, T. (2013). The global epidemiology and contribution of cannabis use and dependence to the global burden of disease: Results from the GBD 2010 study. PloS ONE, 8, e76635. http://doi.org/ 10.1371/journal.pone.0076635
14. Degenhardt, L., Whiteford, H., & Hall, W. D. (2014). The Global Burden of Disease projects: What have we learned about illicit drug use and dependence and their contribution to the global burden of disease? Drug and Alcohol Review, 33, 4-12. http://dx.doi.org/10.1111/dar.12088
15. Deiana, S., Fattore, L., Spano, M. S., Cossu, G., Porcu, E., Fadda, P., & Fratta, W. (2007). Strain and schedule-dependent differences in the acquisition, maintenance and extinction of intravenous cannabinoid selfadministration in rats. Neuropharmacology, 52, 646-654. http://dx.doi .org/10.1016/j.neuropharm.2006.09.007
16. Elsmore, T. F., & Fletcher, G. V. (1972). Delta 9-tetrahydrocannabinol: Aversive effects in rat at high doses. Science, 175, 911-912. http://dx .doi.org/10.1126/science.175.4024.911
17. Englund, A., Morrison, P. D., Nottage, J., Hague, D., Kane, F., Bonaccorso, S.,. Kapur, S. (2013). Cannabidiol inhibits THC-elicited paranoid symptoms and hippocampal-dependent memory impairment. Journal of Psychopharmacology, 27, 19-27. http://doi.org/10.1177/ 0269881112460109
18. Fattore, L., Cossu, G., Martellotta, C. M., & Fratta, W. (2001). Intravenous self-administration of the cannabinoid CB1 receptor agonist WIN 55,212-2 in rats. Psychopharmacology, 156, 410-416. http://dx.doi.org/ 10.1007/s002130100734
19. Fattore, L., Spano, M. S., Altea, S., Angius, F., Fadda, P., & Fratta, W. (2007). Cannabinoid self-administration in rats: Sex differences and the influence of ovarian function. British Journal of Pharmacology, 152, 795-804. http://dx.doi.org/10.1038/sj.bjp.0707465
20. Fattore, L., Spano, M. S., Altea, S., Fadda, P., & Fratta, W. (2010). Drugand cue-induced reinstatement of cannabinoid-seeking behaviour in male and female rats: Influence of ovarian hormones. British Journal of Pharmacology, 160, 724-735. http://dx.doi.org/10.1111/j.1476-5381 .2010.00734.x
21. Fischer, G. J., & Vail, B. J. (1980). Preexposure to delta-9-THC blocks THC-induced conditioned taste aversion in rats. Behavioral and Neural Biology, 30, 191-196. http://dx.doi.org/10.1016/S0163-1047(80)91065-1
22. Ghozland, S., Matthes, H. W. D., Simonin, F., Filliol, D., Kieffer, B. L., & Maldonado, R. (2002). Motivational effects of cannabinoids are mediated by mu-opioid and kappa-opioid receptors. The Journal of Neuroscience, 22, 1146-1154.
23. Haney, M., Malcolm, R. J., Babalonis, S., Nuzzo, P. A., Cooper, Z. D., Bedi, G.,. Walsh, S. L. (2016). Oral cannabidiol does not alter the subjective, reinforcing or cardiovascular effects of smoked cannabis. Neuropsychopharmacology, 41, 1974-1982. http://doi.org/10.1038/npp. 2015.367
24. Hempel, B. J., Wakeford, A. G., Clasen, M. M., Friar, M. A., & Riley, A. L. (2016). Delta-9-tetrahydrocannabinol (THC) history fails to affect THC's ability to induce place preferences in rats. Pharmacology, Biochemistry, and Behavior, 144, 1-6. http://dx.doi.org/10.1016/j.pbb.2016 .02.007
25. Hempel, B. J., Wakeford, A. G. P., Nelson, K. H., Clasen, M. M., Woloshchuk, C. J., & Riley, A. L. (2017). An assessment of sex differences in (9)-tetrahydrocannabinol (THC) taste and place conditioning. Pharmacology, Biochemistry, and Behavior, 153, 69-75. http:// dx.doi.org/10.1016/j.pbb.2016.11.006
26. Hutcheson, D. M., Tzavara, E. T., Smadja, C., Valjent, E., Roques, B. P., Hanoune, J., & Maldonado, R. (1998). Behavioural and biochemical evidence for signs of abstinence in mice chronically treated with delta- 9-tetrahydrocannabinol. British Journal of Pharmacology, 125, 1567-1577. http://dx.doi.org/10.1038/sj.bjp.0702228
27. Jackson, L. R., Robinson, T. E., & Becker, J. B. (2006). Sex differences and hormonal influences on acquisition of cocaine self-administration in rats. Neuropsychopharmacology, 31, 129-138.
28. Justinova, Z., Tanda, G., Redhi, G. H., & Goldberg, S. R. (2003). Selfadministration of delta9-tetrahydrocannabinol (THC) by drug naive squirrel monkeys. Psychopharmacology, 169, 135-140. http://dx.doi .org/10.1007/s00213-003-1484-0
29. Karniol, I. G., & Carlini, E. A. (1973). Pharmacological interaction between cannabidiol and delta 9-tetrahydrocannabinol. Psychopharmacology, 33, 53-70. http://dx.doi.org/10.1007/BF00428793
30. Karniol, I. G., Shirakawa, I., Kasinski, N., Pfeferman, A., & Carlini, E. A. (1974). Cannabidiol interferes with the effects of delta 9-tetrahydrocannabinol in man. European Journal of Pharmacology, 28, 172-177. http://dx.doi.org/10.1016/0014-2999(74)90129-0
31. (9)-tetrahydrocannabinol (THC) behavioural effects and alters THC pharmacokinetics during acute and chronic treatment in adolescent rats. Psychopharmacology, 218, 443-1577. http://doi.org/10.1007/s00213-011-2342-0
32. Lachenmeier, D. W., & Rehm, J. (2015). Comparative risk assessment of alcohol, tobacco, cannabis and other illicit drugs using the margin of exposure approach. Scientific Reports, 5, 8126. http://dx.doi.org/10 .1038/srep08126
33. Lefever, T. W., Marusich, J. A., Antonazzo, K. R., & Wiley, J. L. (2014). Evaluation of WIN 55,212-2 self-administration in rats as a potential cannabinoid abuse liability model. Pharmacology, Biochemistry, and Behavior, 118, 30-35. http://dx.doi.org/10.1016/j.pbb.2014.01.002
34. Leite, J. R., & Carlini, E. A. (1974). Failure to obtain "cannabis-directed behavior" and abstinence syndrome in rats chronically treated with cannabis sativa extracts. Psychopharmacology, 36, 133-145. http://dx .doi.org/10.1007/BF00421785
35. Lepore, M., Vorel, S. R., Lowinson, J., & Gardner, E. L. (1995). Conditioned place preference induced by delta 9-tetrahydrocannabinol: Comparison with cocaine, morphine, and food reward. Life Sciences, 56, 2073-2080. http://dx.doi.org/10.1016/0024-3205(95)00191-8
36. Lynch, W. J., & Taylor, J. R. (2004). Sex differences in the behavioral effects of 24-h/day access to cocaine under a discrete trial procedure. Neuropsychopharmacology, 29, 943-951. http://dx.doi.org/10.1038/sj .npp.1300389
37. Martellotta, M. C., Cossu, G., Fattore, L., Gessa, G. L., & Fratta, W. (1998). Self-administration of the cannabinoid receptor agonist WIN 55,212-2 in drug-naive mice. Neuroscience, 85, 327-330. http://dx.doi .org/10.1016/S0306-4522(98)00052-9
38. National Institute on Drug Abuse. (2016). Research report series: Marijuana. Rockville, MD: Author.
39. National Research Council. (2003). Guidelines for the care and use of mammals in neuroscience and behavioral research. Washington, DC: National Academies Press.
40. National Research Council. (2011). Guide for the care and use of laboratory animals. Washington, DC: National Academies Press.
41. Parker, L. A., & Gillies, T. (1995). THC-induced place and taste aversions in Lewis and Sprague-Dawley rats. Behavioral Neuroscience, 109, 71-78. http://dx.doi.org/10.1037/0735-7044.109.1.71
42. Pertwee, R. G., & Ross, R. A. (2002). Cannabinoid receptors and their ligands. Prostaglandins, Leukotrienes, and Essential Fatty Acids, 66, 101-121. http://dx.doi.org/10.1054/plef.2001.0341
43. Pomfrey, R. L., Bostwick, T. A., Wetzell, B. B., & Riley, A. L. (2015). Adolescent nicotine exposure fails to impact cocaine reward, aversion and self-administration in adult male rats. Pharmacology, Biochemistry, and Behavior, 137, 30-37. http://dx.doi.org/10.1016/j.pbb.2015.08.004
44. Roth, M. E., & Carroll, M. E. (2004a). Sex differences in the acquisition of IV methamphetamine self-administration and subsequent maintenance under a progressive ratio schedule in rats. Psychopharmacology, 172, 443-449. http://dx.doi.org/10.1007/s00213-003-1670-0
45. Roth, M. E., & Carroll, M. E. (2004b). Sex differences in the escalation of intravenous cocaine intake following long- or short-access to cocaine self-administration. Pharmacology, Biochemistry, and Behavior, 78, 199-207. http://dx.doi.org/10.1016/j.pbb.2004.03.018
46. Russo, E., & Guy, G. W. (2006). A tale of two cannabinoids: The therapeutic rationale for combining tetrahydrocannabinol and cannabidiol. Medical Hypotheses, 66, 234 -246. http://dx.doi.org/10.1016/j .mehy.2005.08.026
47. Sañudo-Peña, M. C., Tsou, K., Delay, E. R., Hohman, A. G., Force, M., & Walker, J. M. (1997). Endogenous cannabinoids as an aversive or counter-rewarding system in the rat. Neuroscience Letters, 223, 125-128. http://dx.doi.org/10.1016/S0304-3940(97)13424-3
48. Schramm-Sapyta, N. L., Cha, Y. M., Chaudhry, S., Wilson, W. A., Swartzwelder, H. S., & Kuhn, C. M. (2007). Differential anxiogenic, aversive, and locomotor effects of THC in adolescent and adult rats. Psychopharmacology, 191, 867-877. http://dx.doi.org/10.1007/s00213-006-0676-9
49. Schuster, C. R., & Johanson, C. E. (1974). The use of animal models for the study of drug abuse. Research Advances in Alcohol and Drug Problems, 1, 1-31.
50. Taffe, M. A., Creehan, K. M., & Vandewater, S. A. (2015). Cannabidiol fails to reverse hypothermia or locomotor suppression induced by δ(9)-tetrahydrocannabinol in Sprague-Dawley rats. British Journal of Pharmacology, 172, 1783-1791. http://dx.doi.org/10.1111/bph.13024
51. Takahashi, R. N., & Singer, G. (1979). Self-administration of delta 9-tetrahydrocannabinol by rats. Pharmacology, Biochemistry, and Behavior, 11, 737-740. http://dx.doi.org/10.1016/0091-3057(79)90274-0
52. Takahashi, R. N., & Singer, G. (1980). Effects of body weight levels on cannabis self-injection. Pharmacology, Biochemistry, and Behavior, 13, 877-881. http://dx.doi.org/10.1016/0091-3057(80)90222-1
53. Tanda, G., Munzar, P., & Goldberg, S. R. (2000). Self-administration behavior is maintained by the psychoactive ingredient of marijuana in squirrel monkeys. Nature Neuroscience, 3, 1073-1074. http://dx.doi.org/ 10.1038/80577
54. (9) -tetrahydrocannabinol in mice: Implications for medical cannabis. British Journal of Pharmacology, 173, 53-65. http://dx.doi.org/10.1111/bph.13333
55. United Nations Office on Drugs & Crime. (2014). World drug report 2014. Herndon, VA: United Nations Publications.
56. Valjent, E., & Maldonado, R. (2000). A behavioural model to reveal place preference to delta 9-tetrahydrocannabinol in mice. Psychopharmacology, 147, 436-438. http://dx.doi.org/10.1007/s002130050013
57. (9)- tetrahydrocannabinol. Drug and Alcohol Dependence, 94, 191-198. http://dx.doi.org/10.1016/j.drugalcdep.2007.11.017
58. van Ree, J. M., Slangen, J. L., & de Wied, D. (1978). Intravenous self-administration of drugs in rats. The Journal of Pharmacology and Experimental Therapeutics, 204, 547-557.
59. Varvel, S. A., Wiley, J. L., Yang, R., Bridgen, D. T., Long, K., Lichtman, A. H., & Martin, B. R. (2006). Interactions between THC and cannabidiol in mouse models of cannabinoid activity. Psychopharmacology, 186, 226-234. http://dx.doi.org/10.1007/s00213-006-0356-9
60. (9)-tetrahydrocannabinol in the Fischer (F344) and Lewis (LEW) rat strains. Pharmacology, Biochemistry, and Behavior, 116, 39-44. http://dx.doi.org/10.1016/j.pbb.2013.11.005
61. Weeks, J. R. (1962). Experimental morphine addiction: Method for automatic intravenous injections in unrestrained rats. Science, 138, 143-144. http://dx.doi.org/10.1126/science.138.3537.143
62. Zhang, X. Y., & Kosten, T. A. (2007). Previous exposure to cocaine enhances cocaine self-administration in an alpha 1-adrenergic receptor dependent manner. Neuropsychopharmacology, 32, 638-645. http://dx .doi.org/10.1038/sj.npp.1301120
63. Zimmer, A., Valjent, E., König, M., Zimmer, A. M., Robledo, P., Hahn, H.,. Maldonado, R. (2001). Absence of delta 9-tetrahydrocannabinoldysphoric effects in dynorphin-deficient mice. The Journal of Neuroscience, 21, 9499-9505.
64. Zuardi, A. W., Shirakawa, I., Finkelfarb, E., & Karniol, I. G. (1982). Action of cannabidiol on the anxiety and other effects produced by delta 9-THC in normal subjects. Psychopharmacology, 76, 245-250. http:// dx.doi.org/10.1007/BF00432554